Skip to search formSkip to main contentSkip to account menu

GSK 2248761

Known as: GSK-2248761, GSK2248761 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

IDX 899

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Drug interaction profile for GSK2248761, a next generation non-nucleoside reverse transcriptase inhibitor.
AIM To evaluate potential drug interactions with antiretroviral therapies or supportive therapies for use in conjunction with the… 
2012
2012
Safety and Efficacy of GSK2248761, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor, in Treatment-Naive HIV-1-Infected Subjects
ABSTRACT GSK2248761 is a novel, once-daily (QD), next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)